SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)

SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano) - Hallo sahabat Hidup Sehat, Pada kali ini kita memberikan info menarik tentang kesehatan yang berjudul SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano), saya telah menyediakan artikel artikel menarik tenatang kesehatan tentunya mudah-mudahan isi postingan yang saya tulis ini dapat anda memberikan maanfaat bagi yang membacanya.

Tentang : SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
Apa yang terjadi : SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)

lihat juga


SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)



SemBioSys Genetics, Inc. (Calgary, Canada) has demonstrated that its safflower-produced Apo AI(Milano) is functional in a widely accepted animal model. The company has demonstrated that safflower Apo AI(Milano) increased cholesterol mobilization substantially in mice which, in conjunction with analytical and in vitro assays, indicates that safflower Apo AI(Milano) is physiologically and pharmaceutically comparable to microbially-produced Apo AI. In human trials, microbially-produced Apo AI(Milano) has been shown to remove plaque from arteries (plaque regression), and holds potential for addressing one of the greatest unmet medical needs today—the reversal of atherosclerosis.

Apo AI is a naturally occurring human protein being developed as a cardiovascular therapy to stabilize and reverse atherosclerotic plaque deposition for the prevention and treatment of cardiovascular disease. Apo AI is the major apolipoprotein associated with HDL, which naturally removes plaque from arteries. If successfully commercialized, predicted high dosing (multiple grams per course of patient treatment) coupled with a large patient population would be expected to drive volume demand of several tons of Apo AI(Milano) per year. SemBioSys’ proprietary safflower derived Apo AI(Milano) is a des I, 2 variant of Apo AI(Milano).



Demikianlah Artikel SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)

Sekian dari kami, mudah mudahan artikel SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano), bisa memberi manfaat untuk anda semua. baiklah, sekian postingan dari kami . salam Ayo Hidup Sehat !! .

Anda sedang membaca artikel SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano) dan artikel ini url permalinknya adalah http://kesehatan168.blogspot.com/2008/07/sembiosys-demonstrates-functionality-of_23.html
Artikel Kesehatan Terbaru Lainnya kesehatan,SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
Hidup sehat, sehat, sakit, penyakit,cara mengatasi, obat, kegunaan obat

0 Response to "SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)"

Posting Komentar